Tesofensine (NS-2330) is a centrally acting triple monoamine reuptake inhibitor (SNDRI) that blocks presynaptic reuptake of dopamine, norepinephrine, and serotonin. It is used in laboratory research to study monoaminergic signaling, neurotransmitter regulation, and energy-balance pathways. Preclinical investigations explore its effects on metabolic function, appetite control, and neural pathways associated with dopamine, norepinephrine, and serotonin activity.

For in-vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.